$JNJ Recent News The best way to get into the
Post# of 102473
Posted On: 02/10/2015 12:37:57 PM
$JNJ Recent News
The best way to get into the drug-distribution space 1:20 p.m. Feb. 5, 2015 - The Trading Deck
The most important thing to look for in Amazon’s earnings 12:35 p.m. Jan. 29, 2015 - Ophir Gottlieb
FDA gives investors another reason to like DexCom 11:30 a.m. Jan. 29, 2015 - The Trading Deck
20 dividend stocks to help you rise above low interest rates 11:09 a.m. Jan. 23, 2015 - Philip van Doorn
What happens if the ECB pulls a Swiss-style surprise 7:30 a.m. Jan. 21, 2015 - Barbara Kollmeyer
Updates, advisories and surprises 7:01 p.m. Jan. 20, 2015 - MarketWatch
Netflix surges after earnings, subscriber growth beats 6:33 p.m. Jan. 20, 2015 - Victor Reklaitis
Stocks eke out gains in choppy trade 4:34 p.m. Jan. 20, 2015 - Carla Mozee
Johnson & Johnson sales dented by stronger dollar 12:49 p.m. Jan. 20, 2015 - MarketWatch.com
J&J shares drop 2.2% for biggest loss among Dow stocks 9:34 a.m. Jan. 20, 2015 - Victor Reklaitis
Tue., Jan. 20: Watch Twitter on India Deal 9:32 a.m. Jan. 20, 2015 - MarketWatch
Morgan Stanley Misses on Q4 Earnings 9:30 a.m. Jan. 20, 2015 - MarketWatch
Johnson & Johnson beats profit expectations, but sales fall shy 7:59 a.m. Jan. 20, 2015 - Tomi Kilgore
Johnson & Johnson's stock slips 0.3% permarket after Q4 results 7:50 a.m. Jan. 20, 2015 - Tomi Kilgore
Johnson & Johnson Q4 Remicade sales $1.67 vs. FactSet consensus $1.74 7:50 a.m. Jan. 20, 2015 - Tomi Kilgore
Johnson & Johnson Q4 sales down 0.6% to $18.3 bln; FactSet consensus $18.56 bln 7:48 a.m. Jan. 20, 2015 - Tomi Kilgore
Johnson & Johnson net EPS 89 cents vs. $1.23 a year ago 7:47 a.m. Jan. 20, 2015 - Tomi Kilgore
Johnson & Johnson Q4 adj. EPS $1.27 vs. FactSet consensus $1.25 7:46 a.m. Jan. 20, 2015 - Tomi Kilgore
Earnings, ECB highlight holiday-shortened week 2:50 a.m. Jan. 19, 2015 - Tom Bemis
J&J gets grant to speed up Ebola vaccine 8:13 a.m. Jan. 16, 2015 - Chelsey Dulaney
Total Return Of Stocks With The Largest Following On Seeking Alpha 7:42 a.m. Today - Seeking Alpha
Going Overweight With Gilead In My DGI Portfolio 4:33 p.m. Feb. 9, 2015 - Seeking Alpha
The 4 Stocks That Weighed Down The DJIA on Monday 3:45 p.m. Feb. 9, 2015 - 247WallSt.com
Best Stock Picks For New Investors 2:57 p.m. Feb. 9, 2015 - GuruFocus.com
The Best Fund Families: A Barron’s Exclusive 12:55 p.m. Feb. 9, 2015 - Barrons.com
Own The Portfolio Of The One Percent 7:56 a.m. Feb. 9, 2015 - Seeking Alpha
Johnson and Johnson, Inc. (JNJ): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Feb. 9, 2015 - Zacks.com
4 Reasons to Buy Misunderstood JNJ Stock 12:00 a.m. Feb. 9, 2015 - InvestorPlace.com
Drug Making Breaks Away From Old Ways 8:07 p.m. Feb. 8, 2015 - The Wall Street Journal Interactive Edition
In Perspective: The Ridiculously Large Market Caps Of America's 20 Most Valuable Companies 10:33 a.m. Feb. 8, 2015 - Seeking Alpha
The 4 Stocks That Sank the Dow on Friday 4:04 p.m. Feb. 6, 2015 - 247WallSt.com
Smith & Nephew's Shares Are Risky, Despite the Company's Strong Outlook 3:31 p.m. Feb. 6, 2015 - TheStreet.com
Retirement Strategy: The Frothy Market Beginners Portfolio Grows Cash By Doing Nothing But Owning Shares 11:21 a.m. Feb. 6, 2015 - Seeking Alpha
Is Boston Scientific Worth the Risk? 8:45 a.m. Feb. 6, 2015 - Barrons.com
Pfizer Buying Hospira To Inject Growth Into Generics 4:27 p.m. Feb. 5, 2015 - Investors Business Daily
Stocks Hold Highs as Crude Oil Recovers $50 on Bets of Global Growth 3:16 p.m. Feb. 5, 2015 - TheStreet.com
More Proof of Accelerating Boston Scientific Turnaround 1:24 p.m. Feb. 5, 2015 - 247WallSt.com
Predictable Fast Growing Healthcare Dividend Growth And Growth Stocks For Your Retirement Portfolios: Part 5 11:51 a.m. Feb. 5, 2015 - Seeking Alpha
Pfizer to Buy Hospira for $16 Billion 11:51 a.m. Feb. 5, 2015 - The Wall Street Journal Interactive Edition
Big Pharma Weak Guidance Put These ETFs in Focus - ETF News And Commentary 11:00 a.m. Feb. 5, 2015 - Zacks.com
BRIC Traditional Wound Management Market Outlook to 2020 1:37 p.m. Feb. 9, 2015 - PR Newswire - PRF
Advanced Remote Patient Monitoring Systems, 7th Edition 12:56 p.m. Feb. 9, 2015 - PR Newswire - PRF
McPhadden Samac Tuovi LLP Commences Xarelto Class Action Against Bayer and Janssen 1:32 p.m. Feb. 6, 2015 - Marketwired
Johnson & Johnson Chief Procurement Officer Named as ISM Board Chair 9:00 a.m. Feb. 5, 2015 - PR Newswire - PRF
INC Research Further Strengthens Board of Directors Through Appointment of Pharmaceutical Executive David Norton 2:30 p.m. Feb. 4, 2015 - GlobeNewswire
Marathon Pharmaceuticals Names Greg Aronin Vice President of Government Affairs 9:30 a.m. Feb. 3, 2015 - BusinessWire - BZX
Target, Dow, 3M, Pepsi and More Headline SUSTPACK 2015 11:35 a.m. Jan. 29, 2015 - BusinessWire - BZX
Applied Molecular Transport Announces Research and Development Collaboration with Janssen and Johnson & Johnson Innovation for Novel Therapeutic Candidate to Treat Inflammatory Bowel Diseases 8:30 a.m. Jan. 28, 2015 - PR Newswire - PRF
Young Men Allege Prescription Drug Risperdal Linked to Abnormal Male Breast Development 12:30 p.m. Jan. 27, 2015 - BusinessWire - BZX
Dr. Paul Janssen Award for Biomedical Research Issues 2015 Call for Nominations 9:00 a.m. Jan. 21, 2015 - PR Newswire - PRF
InvestorsObserver releases comments on Johnson & Johnson, American Express, Delta Air Lines, Broadcom Corp., and Meritage Homes 9:31 a.m. Jan. 20, 2015 - PR Newswire - PRF
New Provisional Patents Filed for Pharmaceutical Cannabidiol (CBD) Formulation Consisting of Ibuprofen & CBD Compounds Aimed At Treating Pain 8:45 a.m. Jan. 20, 2015 - PR Newswire - PRF
Johnson & Johnson Reports 2014 Fourth-Quarter and Full-Year Results: 7:45 a.m. Jan. 20, 2015 - PR Newswire - PRF
Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest U.S. License Rights to NUCYNTA® (tapentadol), NUCYNTA® ER (tapentadol) extended-release tablets and NUCYNTA® (tapentadol) Oral Solution 4:05 p.m. Jan. 15, 2015 - PR Newswire - PRF
Wearable Technology in Industry Verticals 2014 - 2019 4:45 p.m. Jan. 14, 2015 - PR Newswire - PRF
DECN Plans New Legal Challenge After LifeScan (J&J) Admits to Using Sworn Testimony From Expert With Falsified Credentials 9:20 a.m. Jan. 14, 2015 - Marketwired
Tissue Regeneration Systems Adds Business Development Executive 5:00 a.m. Jan. 14, 2015 - PR Newswire - PRF
LeeAnn Ali Joins BioBridges as Executive Director, Clinical Operations 8:03 a.m. Jan. 13, 2015 - Marketwired
Janssen and Johnson & Johnson Innovation Announce License Agreement with Vedanta Biosciences for Microbiome Pharmaceutical Candidate for Inflammatory Bowel Disease 8:02 a.m. Jan. 13, 2015 - BusinessWire - BZX
Vedanta Biosciences Announces License Agreement with Janssen and Johnson & Johnson Innovation for Microbiome Pharmaceutical Candidate for Inflammatory Bowel Disease 8:00 a.m. Jan. 13, 2015 - PR Newswire - PRF
The best way to get into the drug-distribution space 1:20 p.m. Feb. 5, 2015 - The Trading Deck
The most important thing to look for in Amazon’s earnings 12:35 p.m. Jan. 29, 2015 - Ophir Gottlieb
FDA gives investors another reason to like DexCom 11:30 a.m. Jan. 29, 2015 - The Trading Deck
20 dividend stocks to help you rise above low interest rates 11:09 a.m. Jan. 23, 2015 - Philip van Doorn
What happens if the ECB pulls a Swiss-style surprise 7:30 a.m. Jan. 21, 2015 - Barbara Kollmeyer
Updates, advisories and surprises 7:01 p.m. Jan. 20, 2015 - MarketWatch
Netflix surges after earnings, subscriber growth beats 6:33 p.m. Jan. 20, 2015 - Victor Reklaitis
Stocks eke out gains in choppy trade 4:34 p.m. Jan. 20, 2015 - Carla Mozee
Johnson & Johnson sales dented by stronger dollar 12:49 p.m. Jan. 20, 2015 - MarketWatch.com
J&J shares drop 2.2% for biggest loss among Dow stocks 9:34 a.m. Jan. 20, 2015 - Victor Reklaitis
Tue., Jan. 20: Watch Twitter on India Deal 9:32 a.m. Jan. 20, 2015 - MarketWatch
Morgan Stanley Misses on Q4 Earnings 9:30 a.m. Jan. 20, 2015 - MarketWatch
Johnson & Johnson beats profit expectations, but sales fall shy 7:59 a.m. Jan. 20, 2015 - Tomi Kilgore
Johnson & Johnson's stock slips 0.3% permarket after Q4 results 7:50 a.m. Jan. 20, 2015 - Tomi Kilgore
Johnson & Johnson Q4 Remicade sales $1.67 vs. FactSet consensus $1.74 7:50 a.m. Jan. 20, 2015 - Tomi Kilgore
Johnson & Johnson Q4 sales down 0.6% to $18.3 bln; FactSet consensus $18.56 bln 7:48 a.m. Jan. 20, 2015 - Tomi Kilgore
Johnson & Johnson net EPS 89 cents vs. $1.23 a year ago 7:47 a.m. Jan. 20, 2015 - Tomi Kilgore
Johnson & Johnson Q4 adj. EPS $1.27 vs. FactSet consensus $1.25 7:46 a.m. Jan. 20, 2015 - Tomi Kilgore
Earnings, ECB highlight holiday-shortened week 2:50 a.m. Jan. 19, 2015 - Tom Bemis
J&J gets grant to speed up Ebola vaccine 8:13 a.m. Jan. 16, 2015 - Chelsey Dulaney
Total Return Of Stocks With The Largest Following On Seeking Alpha 7:42 a.m. Today - Seeking Alpha
Going Overweight With Gilead In My DGI Portfolio 4:33 p.m. Feb. 9, 2015 - Seeking Alpha
The 4 Stocks That Weighed Down The DJIA on Monday 3:45 p.m. Feb. 9, 2015 - 247WallSt.com
Best Stock Picks For New Investors 2:57 p.m. Feb. 9, 2015 - GuruFocus.com
The Best Fund Families: A Barron’s Exclusive 12:55 p.m. Feb. 9, 2015 - Barrons.com
Own The Portfolio Of The One Percent 7:56 a.m. Feb. 9, 2015 - Seeking Alpha
Johnson and Johnson, Inc. (JNJ): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Feb. 9, 2015 - Zacks.com
4 Reasons to Buy Misunderstood JNJ Stock 12:00 a.m. Feb. 9, 2015 - InvestorPlace.com
Drug Making Breaks Away From Old Ways 8:07 p.m. Feb. 8, 2015 - The Wall Street Journal Interactive Edition
In Perspective: The Ridiculously Large Market Caps Of America's 20 Most Valuable Companies 10:33 a.m. Feb. 8, 2015 - Seeking Alpha
The 4 Stocks That Sank the Dow on Friday 4:04 p.m. Feb. 6, 2015 - 247WallSt.com
Smith & Nephew's Shares Are Risky, Despite the Company's Strong Outlook 3:31 p.m. Feb. 6, 2015 - TheStreet.com
Retirement Strategy: The Frothy Market Beginners Portfolio Grows Cash By Doing Nothing But Owning Shares 11:21 a.m. Feb. 6, 2015 - Seeking Alpha
Is Boston Scientific Worth the Risk? 8:45 a.m. Feb. 6, 2015 - Barrons.com
Pfizer Buying Hospira To Inject Growth Into Generics 4:27 p.m. Feb. 5, 2015 - Investors Business Daily
Stocks Hold Highs as Crude Oil Recovers $50 on Bets of Global Growth 3:16 p.m. Feb. 5, 2015 - TheStreet.com
More Proof of Accelerating Boston Scientific Turnaround 1:24 p.m. Feb. 5, 2015 - 247WallSt.com
Predictable Fast Growing Healthcare Dividend Growth And Growth Stocks For Your Retirement Portfolios: Part 5 11:51 a.m. Feb. 5, 2015 - Seeking Alpha
Pfizer to Buy Hospira for $16 Billion 11:51 a.m. Feb. 5, 2015 - The Wall Street Journal Interactive Edition
Big Pharma Weak Guidance Put These ETFs in Focus - ETF News And Commentary 11:00 a.m. Feb. 5, 2015 - Zacks.com
BRIC Traditional Wound Management Market Outlook to 2020 1:37 p.m. Feb. 9, 2015 - PR Newswire - PRF
Advanced Remote Patient Monitoring Systems, 7th Edition 12:56 p.m. Feb. 9, 2015 - PR Newswire - PRF
McPhadden Samac Tuovi LLP Commences Xarelto Class Action Against Bayer and Janssen 1:32 p.m. Feb. 6, 2015 - Marketwired
Johnson & Johnson Chief Procurement Officer Named as ISM Board Chair 9:00 a.m. Feb. 5, 2015 - PR Newswire - PRF
INC Research Further Strengthens Board of Directors Through Appointment of Pharmaceutical Executive David Norton 2:30 p.m. Feb. 4, 2015 - GlobeNewswire
Marathon Pharmaceuticals Names Greg Aronin Vice President of Government Affairs 9:30 a.m. Feb. 3, 2015 - BusinessWire - BZX
Target, Dow, 3M, Pepsi and More Headline SUSTPACK 2015 11:35 a.m. Jan. 29, 2015 - BusinessWire - BZX
Applied Molecular Transport Announces Research and Development Collaboration with Janssen and Johnson & Johnson Innovation for Novel Therapeutic Candidate to Treat Inflammatory Bowel Diseases 8:30 a.m. Jan. 28, 2015 - PR Newswire - PRF
Young Men Allege Prescription Drug Risperdal Linked to Abnormal Male Breast Development 12:30 p.m. Jan. 27, 2015 - BusinessWire - BZX
Dr. Paul Janssen Award for Biomedical Research Issues 2015 Call for Nominations 9:00 a.m. Jan. 21, 2015 - PR Newswire - PRF
InvestorsObserver releases comments on Johnson & Johnson, American Express, Delta Air Lines, Broadcom Corp., and Meritage Homes 9:31 a.m. Jan. 20, 2015 - PR Newswire - PRF
New Provisional Patents Filed for Pharmaceutical Cannabidiol (CBD) Formulation Consisting of Ibuprofen & CBD Compounds Aimed At Treating Pain 8:45 a.m. Jan. 20, 2015 - PR Newswire - PRF
Johnson & Johnson Reports 2014 Fourth-Quarter and Full-Year Results: 7:45 a.m. Jan. 20, 2015 - PR Newswire - PRF
Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest U.S. License Rights to NUCYNTA® (tapentadol), NUCYNTA® ER (tapentadol) extended-release tablets and NUCYNTA® (tapentadol) Oral Solution 4:05 p.m. Jan. 15, 2015 - PR Newswire - PRF
Wearable Technology in Industry Verticals 2014 - 2019 4:45 p.m. Jan. 14, 2015 - PR Newswire - PRF
DECN Plans New Legal Challenge After LifeScan (J&J) Admits to Using Sworn Testimony From Expert With Falsified Credentials 9:20 a.m. Jan. 14, 2015 - Marketwired
Tissue Regeneration Systems Adds Business Development Executive 5:00 a.m. Jan. 14, 2015 - PR Newswire - PRF
LeeAnn Ali Joins BioBridges as Executive Director, Clinical Operations 8:03 a.m. Jan. 13, 2015 - Marketwired
Janssen and Johnson & Johnson Innovation Announce License Agreement with Vedanta Biosciences for Microbiome Pharmaceutical Candidate for Inflammatory Bowel Disease 8:02 a.m. Jan. 13, 2015 - BusinessWire - BZX
Vedanta Biosciences Announces License Agreement with Janssen and Johnson & Johnson Innovation for Microbiome Pharmaceutical Candidate for Inflammatory Bowel Disease 8:00 a.m. Jan. 13, 2015 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼